We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bring photo ID to vote Check what photo ID you'll need to vote in person in the General Election on 4 July.
Protected wine name with Protected Designation of Origin (PDO)
No action is currently needed from patients. No one should stop taking valproate without advice from their healthcare professional.
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
We welcome views on draft regulations for the DOTAS, DASVOIT and POTAS regimes, which amend the existing DOTAS, DASVOIT and POTAS regulations.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (27 December) approved the advanced melanoma medicine Opdualag (nivolumab-relatlimab) for patients from the age of 12.
We are providing an update on a retrospective observational study on the risk to children born to men who took valproate in the 3 months before conception and on the need for the re-analysis of the data from this study...
Employment Tribunal decision.
A summary of recent letters and notifications sent to healthcare professionals about medicines.
This paper presents an ethnographic study of Pratham, one of the most influential NGOs in the domain of education in India today
Teva UK Ltd. has informed the MHRA of a labelling error. This notification provides further advice on the safe use of the product.
Residential Property Tribunal Decision of Judge Judge Shepherd & Anthony Harris LLM FRICS FCIArb on 20th September 2023
In this first study of a combination microbicide vaginal ring, all 4 rings were safe and well tolerated
Employment Appeal Tribunal judgment of Mrs Justice Eady on 20 May 2024.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).